View
2
Download
0
Category
Preview:
Citation preview
Curetis GmbH Max-Eyth-Str. 42 | 71088 Holzgerlingen | GermanyTel.: +49 (0)7031 49195 65 | Email: pharma@curetis.com
Ares Genetics GmbH Karl-Farkas-Gasse 18 | 1030 Vienna | AustriaTel.: +43 (0)1 361 8880 | Email: pharma@ares-genetics.com
We offer a comprehensive portfolio of solutions for antimicrobial drug discovery, clinical development, and product lifecycle management. Our solutions aim at supporting data-driven target and lead prioritization, accelerating clinical trials, augmenting clinical data for regulatory submissions, and informed antimicrobial drug use for effective antibiotic stewardship post launch.
Your partner for antimicrobial drug development
Next Level Solutions for Molecular Microbiology & Data Intelligence in Antimicrobial Drug Development
Member of ABx DevelopmentInforming
Accelerate R&D
Augment Clinical Data
Prescribe Effectively
www.curetis.com
www.ares-genetics.com
00605 Rev. 1.0 © Curetis GmbH
Caution – Investigational Device. Limited by Federal US Law to investigational Use. Not available for Sale in the United States.
Advanced Bioinformatics and Artificial Intelligence for AMR
AMR Target ID and MoA studies
Lead compound prioritization
AMR prediction at molecular level
Deep pathogen characterization in discovery, clinical development, and surveillance
The world’s most comprehensive database on the genetics of antimicrobial resistance
24/7 molecular testing
In any lab or at point-of-care
Results in 1-4 hours
Comprehensive off-the-shelf panels
Customized panels tailored to drug
The any-plex solution for detection of pathogens and genetic antimicrobial resistance markers
Rapid molecular diagnostics for clinical trials and LCM
1 A30 RQ Analzyer in development. Design concept. Actual product may differ.
ARES Technology Platform
Molecular microbiology data intelligence
L4 C8 A50 A30 RQ1
Preclinical Clinical Trials Product Lifecycle Management
Target and MoA Analysis Customized in silico target characterization, epidemiology, and MoA analysis.
Lead Prioritization In vitro high throughput resistance testing combined with customized in silico data analysis solutions to predict likelihood and mechanisms of resistance.
MDx Development
Advanced in silico tools combined with profound experience in molecular microbiology
assay design for clinical trial and companion diagnostic use.
ABx Research and Discovery
Deep Pathogen Characterization
Deep profiling of pathogens using whole genome sequencing to enrich clinical trial data for regulatory submissions.
Optimized Enrolment Customized and off-the-shelf multipex PCR panels for pathogens and resistance
markers enabling rapid, and targeted clinical trial enrolment.
POC HospitalLab
CentralLab
Companion DiagnosticsCustomized multiplex PCR panels for rapid diagnostics
and informed treatment decisions.
Molecular EpidemiologyPost-market surveillance, resistance evolution
monitoring and services.
Streamlined trials and enriched trial datareduce development costs
Increased revenues
Improved product lifecycleFast-tracked development
Informed decisions by data-driven target and lead selection and validation
Biomarker DiscoveryIdentification, validation and epidemiological assessment of ABx drug-specific
biomarkers for clinical trials and companion diagnsotics.
Recommended